Ectodermal dysplasia and immunodeficiency 2: genes and variants
Explore variant evidence for Ectodermal dysplasia and immunodeficiency 2 across 1 analyzed protein (NFKBIA). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 111 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Ectodermal dysplasia and immunodeficiency 2
NFKBIA: NF-kappa-B inhibitor alpha
It sequesters NF-kappaB transcription factors in the cytoplasm until immune or stress signals trigger its degradation. Dominant gain-of-function variants that resist degradation can cause severe immunodeficiency with ectodermal abnormalities.
5 ClinVar pathogenic / likely pathogenic and 121 uncertain variants in NFKBIA have source records linked to Ectodermal dysplasia and immunodeficiency 2. Association strength is not clinical gene validity.
Where Ectodermal dysplasia and immunodeficiency 2 variants cluster
- NFKBIA Destruction motif (positions 30–36): 5 of 5 ClinVar pathogenic / likely pathogenic variants, 45.3× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Ectodermal dysplasia and immunodeficiency 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NFKBIA S32N | 32 | Destruction motif | Pathogenic / likely pathogenic (★★) |
| NFKBIA S32I | 32 | Destruction motif | Pathogenic / likely pathogenic |
| NFKBIA S32R | 32 | Destruction motif | Pathogenic / likely pathogenic |
| NFKBIA S32G | 32 | Destruction motif | Pathogenic / likely pathogenic |
| NFKBIA S36Y | 36 | Destruction motif | Pathogenic / likely pathogenic |
Frequently asked questions
Which genes have records linked to Ectodermal dysplasia and immunodeficiency 2?
This view contains 1 analyzed proteins: NFKBIA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 111 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 153 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center